Augmenix
204 2nd Avenue
Waltham
Massachusetts
02451
United States
Tel: 781-895-3235
Fax: 781-895-3236
Website: http://www.augmenix.com/
Email: bpoff@augmenix.com
31 articles about Augmenix
-
Augmenix Financing Will Enable Sales Growth
7/13/2016
-
Augmenix Announces The Publication Of The Spaceoar Hydrogel Pivotal Clinical Study Results: Application Technique And Patient Tolerance In Men Undergoing Prostate Cancer Radiotherapy
3/31/2016
-
Augmenix’ SpaceOAR System Experiences Rapid U.S. Adoption
10/15/2015
-
Augmenix Announces Publication Of Spaceoar System Clinical Trial Results In Leading Radiation Oncology Journal
6/11/2015
-
Augmenix Announces FDA Clearance Of SpaceOAR System
4/2/2015
-
Massachusett's Augmenix $10.8 Million Series D
7/24/2014
-
Augmenix Receives FDA Clearance to Market Its TraceIT™ Tissue Marker
1/28/2013
-
Varian Medical Systems Makes $15 Million Equity Investment and Obtains Option to Purchase Augmenix
5/12/2011
-
Augmenix Announces First Commercial Use of SpaceOAR(TM) System for Prostate-Rectum Separation in Prostate Cancer Patients Undergoing Radiation Therapy
8/12/2010
-
Augmenix Closes $6.1 Million Financing
10/19/2009
-
Medical Device Developer Augmenix Raises $4.7 Million
7/27/2009